F-star Therapeutics, Inc.
Q4 2021 Earnings Call Transcript

Published:

  • Disclaimer*:
    This transcript is designed to be used alongside the freely available audio recording on this page. Timestamps within the transcript are designed to help you navigate the audio should the corresponding text be unclear. The machine-assisted output provided is partly edited and is designed as a guide.
  • Operator:
    00
  • Lindsey Trickett:
    00
  • Eliot Forster:
    Thank you. Lindsey. Good morning, everyone. Welcome, and thanks for joining F-star’s fourth quarter 2021 earnings call. It's great to speak with you today. I'm very pleased to review the past year of accomplishments and excited to provide an outlook on all we hope to achieve in 2022. 2021 was our first full year as a NASDAQ listed company. It was a stellar year for F-star. There was real progress across every aspect of our business. All 4 of our clinical programs progressed well, successfully navigating COVID. We were -- we added 2 new partners continue to strengthen our patent portfolio and closed a significant financing. 02
  • Darlene Deptula-Hicks:
    15
  • Operator:
    21
  • Hartaj Singh:
    21
  • Eliot Forster:
    22
  • Hartaj Singh:
    22
  • Eliot Forster:
    23
  • Hartaj Singh:
    24
  • Eliot Forster:
    24
  • Operator:
    24
  • Daina Graybosch:
    24
  • Eliot Forster:
    25
  • Daina Graybosch:
    26
  • Eliot Forster:
    27
  • Daina Graybosch:
    28
  • Eliot Forster:
    29
  • Operator:
    29
  • Matt Phipps:
    29
  • Eliot Forster:
    39
  • Matt Phipps:
    30
  • Eliot Forster:
    30
  • Matt Phipps:
    31
  • Eliot Forster:
    31
  • Matt Phipps:
    32
  • Eliot Forster:
    32
  • Operator:
    32
  • Justin Walsh:
    32
  • Eliot Forster:
    32
  • Justin Walsh:
    34
  • Eliot Forster:
    34
  • Justin Walsh:
    36
  • Eliot Forster:
    36
  • Operator:
    36
  • Yale Jen:
    36
  • Eliot Forster:
    37
  • Yale Jen:
    38
  • Eliot Forster:
    39
  • Yale Jen:
    40
  • Eliot Forster:
    40
  • Operator:
    41
  • Jason Shieh:
    41
  • Eliot Forster:
    41
  • Jason Shieh:
    44
  • Eliot Forster:
    44
  • Jason Shieh:
    46
  • Eliot Forster:
    46
  • Jason Shieh:
    46
  • Eliot Forster:
    46
  • Operator:
    47
  • Eliot Forster:
    47
  • Operator:
    48

Other F-star Therapeutics, Inc. earnings call transcripts: